Czejka M - Search Results

1

Hepatic arterial infusion of irinotecan and EmboCept^® S results in high tumor concentration of SN-38 in a rat model of colorectal liver metastases.

Kauffels A, Kitzmüller M, Gruber A, Nowack H, Bohnenberger H, Spitzner M, Kuthning A, Sprenger T, Czejka M, Ghadimi M, Sperling J. Kauffels A, et al. Among authors: czejka m. Clin Exp Metastasis. 2019 Feb;36(1):57-66. doi: 10.1007/s10585-019-09954-5. Epub 2019 Jan 24. Clin Exp Metastasis. 2019. PMID: 30680598

2

Monitoring of erlotinib in pancreatic cancer patients during long-time administration and comparison to a physiologically based pharmacokinetic model.

Gruber A, Czejka M, Buchner P, Kitzmueller M, Kirchbaumer Baroian N, Dittrich C, Sahmanovic Hrgovcic A. Gruber A, et al. Among authors: czejka m. Cancer Chemother Pharmacol. 2018 Apr;81(4):763-771. doi: 10.1007/s00280-018-3545-4. Epub 2018 Feb 16. Cancer Chemother Pharmacol. 2018. PMID: 29453635 Free PMC article.

3

Metabolic activation of irinotecan during intra-arterial chemotherapy of metastatic colorectal cancer.

Czejka M, Kiss A, Koessner C, Terkola R, Ettlinger D, Schueller J. Czejka M, et al. Anticancer Res. 2011 Oct;31(10):3573-8. Anticancer Res. 2011. PMID: 21965780 Clinical Trial.

4

Pharmacokinetics of irinotecan in combination with biweekly cetuximab in patients with advanced colorectal cancer.

Czejka M, Gruenberger B, Kiss A, Farkouh A, Schueller J. Czejka M, et al. Anticancer Res. 2010 Jun;30(6):2355-60. Anticancer Res. 2010. PMID: 20651393

5

Pharmacokinetics and metabolism of irinotecan combined with capecitabine in patients with advanced colorectal cancer.

Czejka M, Schueller J, Hauer K, Ostermann E. Czejka M, et al. Anticancer Res. 2005 Jul-Aug;25(4):2985-90. Anticancer Res. 2005. PMID: 16080556 Free article. Clinical Trial.

6

Enzyme and Transporter Kinetics for CPT-11 (Irinotecan) and SN-38: An Insight on Tumor Tissue Compartment Pharmacokinetics Using PBPK.

Fan Y, Mansoor N, Ahmad T, Wu ZX, Khan RA, Czejka M, Sharib S, Ahmed M, Chen ZS, Yang DH. Fan Y, et al. Among authors: czejka m. Recent Pat Anticancer Drug Discov. 2019;14(2):177-186. doi: 10.2174/1574892814666190212164356. Recent Pat Anticancer Drug Discov. 2019. PMID: 30760193

7

Pharmacokinetics of mitomycin C in patients after bolus injection and chemobolisation of the hepatic artery with Spherex starch particles.

Czejka MJ, Jäger W, Schüller J. Czejka MJ, et al. Eur J Drug Metab Pharmacokinet. 1992 Apr-Jun;17(2):85-7. doi: 10.1007/BF03188775. Eur J Drug Metab Pharmacokinet. 1992. PMID: 1425815

8

Pharmacokinetics of mitoxantrone in patients after 2 h and 24 h intra-arterial administration.

Czejka MJ, Jäger W, Georgopoulos A, Schüller J. Czejka MJ, et al. Eur J Drug Metab Pharmacokinet. 1990 Jul-Sep;15(3):219-22. doi: 10.1007/BF03190207. Eur J Drug Metab Pharmacokinet. 1990. PMID: 2253652

9

Physiologically based pharmacokinetic modeling for predicting irinotecan exposure in human body.

Fan Y, Mansoor N, Ahmad T, Khan RA, Czejka M, Sharib S, Yang DH, Ahmed M. Fan Y, et al. Among authors: czejka m. Oncotarget. 2017 Jul 18;8(29):48178-48185. doi: 10.18632/oncotarget.18380. Oncotarget. 2017. PMID: 28636998 Free PMC article.

10

Impact of co-administered drugs on drug monitoring of capecitabine in patients with advanced colorectal cancer.

Schreiber V, Kitzmueller M, Poxhofer M, Gintersdorfer S, Neudorfer C, Lichtneckert M, Dittrich C, Czejka M. Schreiber V, et al. Among authors: czejka m. Anticancer Res. 2014 Jul;34(7):3371-6. Anticancer Res. 2014. PMID: 24982342

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

76 results

Search Page